Myxofibrosarcoma

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma [Phase 1]

  Phase 1 trial evaluating the safety of low-dose pegylated liposomal doxorubicin in combination with peposertib for advanced sarcoma; current…

• CLINICAL_TRIALS trial_result · 2025-09-23
  Clinical Trial Update: CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma [Phase 1, Phase 2]

  Clinical trial update indicates the Phase 1/Phase 2 safety and efficacy study of CAB-AXL-ADC in adult and adolescent patients with Undiffere…

• CLINICAL_TRIALS trial_result · 2025-08-28
  Clinical Trial Update: Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas [Phase 1]

  Phase 1 study of DCC-3014 in combination with Avelumab in patients with advanced or metastatic sarcoma has completed; no efficacy data is pr…

• CLINICAL_TRIALS trial_result · 2023-11-07
  Clinical Trial Update: Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]

  Phase 2 trial evaluating doxorubicin with upfront dexrazoxane for advanced or metastatic soft tissue sarcoma has completed enrollment with r…

• CLINICAL_TRIALS trial_result · 2016-12-28
  Clinical Trial Update: Alisertib in Treating Patients With Advanced or Metastatic Sarcoma [Phase 2]

  A Phase 2 trial update of alisertib in patients with advanced or metastatic soft tissue sarcomas, including myxofibrosarcoma and several his…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.